Head and Neck Cancer Trails

RTOG 0920

A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Ceruximab for Locally-advanced Resected Head and Neck Cancer

Purpose

This trial is studying radiation therapy to see how well it works compared with radiation therapy given together with cetuximab in treating patients who have undergone surgery for locally advanced head and neck cancer.

Eligibility:

This study is looking for patients with squamous cell carcinoma of oral cavity, oropharynx, or larynx.

Learn more about this study

Parkview Cancer Institute
11050 Parkview Circle
Fort Wayne, Indiana 46845

Search By Cancer Type

 

Need assistance?

Contact us